Tran and Anand proposed regimens of oral antiplatelet drugs for patients with stable coronary artery disease. Effective oral antiplatelet therapy can help reduce ischemic events in these patients.
(1) initial choice of oral antiplatelet therapy
(2) occurrence of TIA or stroke
(3) occurrence of an acute coronary syndrome (ACS)
Initial choice of oral antiplatelet therapy can either be:
Factors that may be considered in initial choice:
(1) allergic reactions to aspirin
(3) aspirin resistance
Indications for switching to aspirin + clopidogrel:
(2) acute coronary syndrome
Exception: initial drug aspirin and TIA/stroke (see below)
Alternatives to aspirin + clopidogrel:
To read more or access our algorithms and calculators, please log in or register.